TELMISARTAN AND AMLODIPINE

TELMISARTAN AND AMLODIPINE was reported 100 times

These side effects are most commonly reported by patients taking TELMISARTAN AND AMLODIPINE:

# Side effect Count
0 DYSPNOEA 11
1 CONSTIPATION 9
2 TOXICITY TO VARIOUS AGENTS 8
3 HYPOTENSION 7
4 RASH 7
5 BLOOD PRESSURE INCREASED 6
6 COUGH 6
7 DIARRHOEA 6
8 FALL 6
9 PAIN 6
10 ANGIOEDEMA 5
11 DECREASED APPETITE 5
12 DEPRESSED LEVEL OF CONSCIOUSNESS 5
13 INTENTIONAL OVERDOSE 5
14 MOBILITY DECREASED 5
15 OFF LABEL USE 5
16 VOMITING 5
17 ARTHRALGIA 4
18 BALANCE DISORDER 4
19 BLOOD CALCIUM DECREASED 4
20 CARDIAC FAILURE 4
21 COGNITIVE DISORDER 4
22 CREATININE RENAL CLEARANCE DECREASED 4
23 DRUG INEFFECTIVE 4
24 FATIGUE 4
25 HEADACHE 4
26 NAUSEA 4
27 ORTHOSTATIC HYPOTENSION 4
28 RENAL DISORDER 4
29 SEDATION 4
30 SEDATION COMPLICATION 4
31 ABDOMINAL PAIN 3
32 ACUTE KIDNEY INJURY 3
33 BLOOD CREATININE INCREASED 3
34 CREATININE RENAL CLEARANCE INCREASED 3
35 DEMENTIA 3
36 DRUG ABUSE 3
37 DRUG INTERACTION 3
38 FEBRILE NEUTROPENIA 3
39 GAIT DISTURBANCE 3
40 HEART RATE INCREASED 3
41 HYPERFERRITINAEMIA 3
42 HYPERTENSION 3
43 IMMUNE-MEDIATED MYOSITIS 3
44 METABOLIC ACIDOSIS 3
45 NASOPHARYNGITIS 3
46 OEDEMA PERIPHERAL 3
47 OVERDOSE 3
48 PNEUMONIA 3
49 PRODUCT USE IN UNAPPROVED INDICATION 3
50 PRURITUS 3
51 RENAL FUNCTION TEST ABNORMAL 3
52 RHINORRHOEA 3
53 SUICIDE ATTEMPT 3
54 VERTIGO 3
55 VISION BLURRED 3
56 ADVERSE DRUG REACTION 2
57 ANAEMIA 2
58 ASTHENIA 2
59 BACK PAIN 2
60 BLADDER DISORDER 2
61 BLINDNESS TRANSIENT 2
62 BLOOD POTASSIUM INCREASED 2
63 BLOOD PRESSURE DECREASED 2
64 BRONCHITIS 2
65 CELLULITIS 2
66 CHEST DISCOMFORT 2
67 CONDITION AGGRAVATED 2
68 COVID-19 2
69 DEHYDRATION 2
70 DISCOMFORT 2
71 DIZZINESS 2
72 DYSLIPIDAEMIA 2
73 DYSPEPSIA 2
74 EYE PAIN 2
75 HAEMODYNAMIC INSTABILITY 2
76 HAEMOGLOBIN DECREASED 2
77 HEPATIC FUNCTION ABNORMAL 2
78 HOT FLUSH 2
79 HYPERGASTRINAEMIA 2
80 HYPERHIDROSIS 2
81 HYPOGLYCAEMIA 2
82 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
83 INJECTION SITE SWELLING 2
84 LACTIC ACIDOSIS 2
85 LINEAR IGA DISEASE 2
86 LOCALISED OEDEMA 2
87 LOSS OF CONSCIOUSNESS 2
88 MALAISE 2
89 MEMORY IMPAIRMENT 2
90 METASTATIC MALIGNANT MELANOMA 2
91 NEUROENDOCRINE TUMOUR 2
92 NEUROPATHY PERIPHERAL 2
93 NORMAL TENSION GLAUCOMA 2
94 OROPHARYNGEAL PAIN 2
95 OSTEOARTHRITIS 2
96 OXYGEN SATURATION DECREASED 2
97 PAIN IN EXTREMITY 2
98 PNEUMOTHORAX 2
99 POLLAKIURIA 2
100 PRODUCT DOSE OMISSION ISSUE 2
101 PSORIASIS 2
102 PYREXIA 2
103 SEASONAL ALLERGY 2
104 SEPSIS 2
105 SHOCK 2
106 SINUSITIS 2
107 SOMNOLENCE 2
108 TEMPERATURE INTOLERANCE 2
109 WEIGHT DECREASED 2
110 WHITE BLOOD CELL COUNT INCREASED 2
111 ABDOMINAL ADHESIONS 1
112 ACCIDENTAL OVERDOSE 1
113 ACUTE CORONARY SYNDROME 1
114 ACUTE MYOCARDIAL INFARCTION 1
115 AGRANULOCYTOSIS 1
116 ALBUMIN URINE PRESENT 1
117 ALTERED STATE OF CONSCIOUSNESS 1
118 AMNESIA 1
119 ANAL FUNGAL INFECTION 1
120 ANGINA PECTORIS 1
121 ANXIETY 1
122 AQUAGENIC PRURITUS 1
123 ARTHROPATHY 1
124 ASPARTATE AMINOTRANSFERASE INCREASED 1
125 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1
126 ATRIAL FIBRILLATION 1
127 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1
128 BACTERIAL INFECTION 1
129 BACTERIAL TEST POSITIVE 1
130 BACTERIAL VAGINOSIS 1
131 BASAL CELL CARCINOMA 1
132 BLADDER CANCER 1
133 BLAST CELL COUNT INCREASED 1
134 BLISTER 1
135 BLISTER RUPTURE 1
136 BLOOD ALBUMIN DECREASED 1
137 BLOOD BETA-D-GLUCAN INCREASED 1
138 BLOOD CREATININE DECREASED 1
139 BLOOD GLUCOSE INCREASED 1
140 BLOOD KETONE BODY 1
141 BLOOD LACTIC ACID INCREASED 1
142 BLOOD POTASSIUM DECREASED 1
143 BLOOD PRESSURE ABNORMAL 1
144 BLOOD PRESSURE DIASTOLIC INCREASED 1
145 BLOOD PRESSURE FLUCTUATION 1
146 BLOOD THYROID STIMULATING HORMONE INCREASED 1
147 BLOOD UREA INCREASED 1
148 BLOOD URIC ACID DECREASED 1
149 BODY TEMPERATURE INCREASED 1
150 BRADYCARDIA 1
151 C-REACTIVE PROTEIN INCREASED 1
152 CATARACT 1
153 CEREBROVASCULAR ACCIDENT 1
154 CHEST PAIN 1
155 CHILLS 1
156 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
157 COLITIS MICROSCOPIC 1
158 COMPARTMENT SYNDROME 1
159 CONFUSIONAL STATE 1
160 CONTUSION 1
161 CORTISOL DECREASED 1
162 CYTOGENETIC ANALYSIS ABNORMAL 1
163 CYTOKINE RELEASE SYNDROME 1
164 DEPRESSION 1
165 DERMATITIS 1
166 DERMATITIS EXFOLIATIVE GENERALISED 1
167 DIABETES MELLITUS 1
168 DIABETES MELLITUS INADEQUATE CONTROL 1
169 DISSEMINATED INTRAVASCULAR COAGULATION 1
170 DRUG HYPERSENSITIVITY 1
171 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
172 DRUG-INDUCED LIVER INJURY 1
173 DRY MOUTH 1
174 DYSKINESIA 1
175 DYSPHAGIA 1
176 DYSPHONIA 1
177 DYSPNOEA EXERTIONAL 1
178 EAR PAIN 1
179 EMPYEMA 1
180 EOSINOPHILIA 1
181 ERYTHEMA 1
182 ESCHERICHIA URINARY TRACT INFECTION 1
183 EYE PRURITUS 1
184 FEELING ABNORMAL 1
185 FEELING COLD 1
186 FEELING HOT 1
187 FLUID RETENTION 1
188 FRUSTRATION TOLERANCE DECREASED 1
189 FUNGAL INFECTION 1
190 FURUNCLE 1
191 GAIT INABILITY 1
192 GALLBLADDER CANCER 1
193 GASTRIC ULCER 1
194 GENERAL PHYSICAL HEALTH DETERIORATION 1
195 GENERALISED TONIC-CLONIC SEIZURE 1
196 GLAUCOMA 1
197 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
198 HAEMODIALYSIS 1
199 HOSPITALISATION 1
200 HYPERGLYCAEMIA 1
201 HYPERKALAEMIA 1
202 HYPERPHAGIA 1
203 HYPERSENSITIVITY 1
204 HYPERSENSITIVITY PNEUMONITIS 1
205 HYPOAESTHESIA 1
206 ILEUS PARALYTIC 1
207 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1
208 IMPETIGO 1
209 INFLUENZA 1
210 INFLUENZA LIKE ILLNESS 1
211 INFUSION RELATED REACTION 1
212 INFUSION SITE DISCHARGE 1
213 INFUSION SITE ERYTHEMA 1
214 INFUSION SITE MASS 1
215 INFUSION SITE PRURITUS 1
216 INJECTION SITE DISCOMFORT 1
217 INJECTION SITE ERYTHEMA 1
218 INJECTION SITE PAIN 1
219 INVESTIGATION ABNORMAL 1
220 JOINT NOISE 1
221 KOEBNER PHENOMENON 1
222 LETHARGY 1
223 LIMB MASS 1
224 LIP DRY 1
225 LIVER DISORDER 1
226 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
227 LUNG OPACITY 1
228 MANIA 1
229 MEAN CELL VOLUME DECREASED 1
230 MECHANICAL ILEUS 1
231 METASTASES TO BONE 1
232 METASTASES TO PERITONEUM 1
233 METASTASES TO PLEURA 1
234 MIGRAINE 1
235 MONOCYTE COUNT INCREASED 1
236 MOUTH HAEMORRHAGE 1
237 MULTIPLE DRUG THERAPY 1
238 MUSCLE ATROPHY 1
239 MUSCLE SPASMS 1
240 MUSCULAR WEAKNESS 1
241 MUSCULOSKELETAL DISCOMFORT 1
242 MUSCULOSKELETAL DISORDER 1
243 MUSCULOSKELETAL STIFFNESS 1
244 MYALGIA 1
245 NECK PAIN 1
246 NEEDLE ISSUE 1
247 NEPHRITIS 1
248 NEPHROLITHIASIS 1
249 NEPHROPATHY TOXIC 1
250 NEUTROPHIL COUNT INCREASED 1
251 NIGHT SWEATS 1
252 NOCARDIOSIS 1
253 NON-SMALL CELL LUNG CANCER 1
254 OBESITY 1
255 OLIGURIA 1
256 ORAL CANDIDIASIS 1
257 ORAL HERPES 1
258 OROPHARYNGEAL DISCOMFORT 1
259 OSTEOMYELITIS 1
260 OVERWEIGHT 1
261 PALLOR 1
262 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
263 PARAESTHESIA 1
264 PARKINSON^S DISEASE 1
265 PELVIC FRACTURE 1
266 PEMPHIGOID 1
267 PERICARDIAL EFFUSION 1
268 PERIPHERAL COLDNESS 1
269 PERIPHERAL SWELLING 1
270 PHOTOPHOBIA 1
271 PLATELET COUNT DECREASED 1
272 PLATELET COUNT INCREASED 1
273 PLATELET DISORDER 1
274 PLEURAL EFFUSION 1
275 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
276 POLYDIPSIA 1
277 PRECANCEROUS MUCOSAL LESION 1
278 PRODUCT ADMINISTRATION INTERRUPTED 1
279 PRODUCT DELIVERY MECHANISM ISSUE 1
280 PRODUCT USE ISSUE 1
281 PRODUCTIVE COUGH 1
282 PROSTATE CANCER 1
283 PROTEIN URINE PRESENT 1
284 PROTEINURIA 1
285 PSYCHOTIC DISORDER 1
286 PULMONARY EMBOLISM 1
287 PULMONARY HYPERTENSION 1
288 PULSE ABNORMAL 1
289 PYELONEPHRITIS 1
290 RED BLOOD CELL COUNT DECREASED 1
291 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
292 REFLUX GASTRITIS 1
293 RENAL IMPAIRMENT 1
294 RESPIRATORY TRACT CONGESTION 1
295 RESTRICTIVE PULMONARY DISEASE 1
296 RHEUMATOID ARTHRITIS 1
297 ROOT CANAL INFECTION 1
298 SCAB 1
299 SEPTIC SHOCK 1
300 SINUS PAIN 1
301 SINUS TACHYCARDIA 1
302 SKIN BURNING SENSATION 1
303 SKIN DISORDER 1
304 SKIN LACERATION 1
305 SKIN OEDEMA 1
306 SKIN WARM 1
307 SLEEP APNOEA SYNDROME 1
308 SPEECH DISORDER 1
309 SPUTUM ABNORMAL 1
310 SQUAMOUS CELL CARCINOMA OF SKIN 1
311 STRESS 1
312 SUBCUTANEOUS ABSCESS 1
313 SUICIDAL IDEATION 1
314 SURGERY 1
315 SWOLLEN TONGUE 1
316 SYNCOPE 1
317 TACHYCARDIA 1
318 THERAPEUTIC PRODUCT EFFECT DECREASED 1
319 THERAPEUTIC RESPONSE DECREASED 1
320 THERAPEUTIC RESPONSE UNEXPECTED 1
321 THERMAL BURN 1
322 THROAT IRRITATION 1
323 THYROID DISORDER 1
324 TONSILLITIS 1
325 TUBERCULOSIS 1
326 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1
327 URINARY TRACT INFECTION 1
328 VAGINAL INFECTION 1
329 VASOPLEGIA SYNDROME 1
330 VISUAL IMPAIRMENT 1
331 VULVOVAGINAL MYCOTIC INFECTION 1
332 WEIGHT INCREASED 1
333 WHEEZING 1
334 WHITE BLOOD CELL COUNT DECREASED 1
335 WHITE BLOOD CELLS URINE POSITIVE 1
336 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1